383 related articles for article (PubMed ID: 23816412)
1. Recommended precaution procedures protect healthcare workers from Crimean-Congo hemorrhagic fever virus.
Gozel MG; Dokmetas I; Oztop AY; Engin A; Elaldi N; Bakir M
Int J Infect Dis; 2013 Nov; 17(11):e1046-50. PubMed ID: 23816412
[TBL] [Abstract][Full Text] [Related]
2. The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region.
Ergonul O; Zeller H; Celikbas A; Dokuzoguz B
Int J Infect Dis; 2007 Jan; 11(1):48-51. PubMed ID: 16600655
[TBL] [Abstract][Full Text] [Related]
3. Contact tracing and serosurvey among healthcare workers exposed to Crimean-Congo haemorrhagic fever in Greece.
Maltezou HC; Maltezos E; Papa A
Scand J Infect Dis; 2009; 41(11-12):877-80. PubMed ID: 19922073
[TBL] [Abstract][Full Text] [Related]
4. Crimean Congo hemorrhagic fever serosurvey in humans for identifying high-risk populations and high-risk areas in the endemic state of Gujarat, India.
Mourya DT; Yadav PD; Gurav YK; Pardeshi PG; Shete AM; Jain R; Raval DD; Upadhyay KJ; Patil DY
BMC Infect Dis; 2019 Feb; 19(1):104. PubMed ID: 30709372
[TBL] [Abstract][Full Text] [Related]
5. Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions.
Mardani M; Rahnavardi M; Rajaeinejad M; Naini KH; Chinikar S; Pourmalek F; Rostami M; Shahri MH
Am J Trop Med Hyg; 2007 Mar; 76(3):443-5. PubMed ID: 17360865
[TBL] [Abstract][Full Text] [Related]
6. Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever?
Guner R; Hasanoglu I; Tasyaran MA; Yapar D; Keske S; Guven T; Yilmaz GR
Vector Borne Zoonotic Dis; 2014 Aug; 14(8):601-5. PubMed ID: 25072991
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of knowledge of the healthcare personnel working in Giresun province regarding Crimean-Congo hemorrhagic fever before and after educational training.
Koculu S; Oncul A; Onal O; Yesilbag Z; Uzun N
J Vector Borne Dis; 2015 Jun; 52(2):166-70. PubMed ID: 26119550
[TBL] [Abstract][Full Text] [Related]
8. Knowledge and attitude toward Crimean-Congo haemorrhagic fever in occupationally at-risk Iranian healthcare workers.
Rahnavardi M; Rajaeinejad M; Pourmalek F; Mardani M; Holakouie-Naieni K; Dowlatshahi S
J Hosp Infect; 2008 May; 69(1):77-85. PubMed ID: 18395295
[TBL] [Abstract][Full Text] [Related]
9. Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia.
Fletcher TE; Gulzhan A; Ahmeti S; Al-Abri SS; Asik Z; Atilla A; Beeching NJ; Bilek H; Bozkurt I; Christova I; Duygu F; Esen S; Khanna A; Kader Ç; Mardani M; Mahmood F; Mamuchishvili N; Pshenichnaya N; Sunbul M; Yalcin TY; Leblebicioglu H
PLoS One; 2017; 12(9):e0182315. PubMed ID: 28886039
[TBL] [Abstract][Full Text] [Related]
10. Probable Crimean-Congo hemorrhagic fever virus transmission occurred after aerosol-generating medical procedures in Russia: nosocomial cluster.
Pshenichnaya NY; Nenadskaya SA
Int J Infect Dis; 2015 Apr; 33():120-2. PubMed ID: 25576827
[TBL] [Abstract][Full Text] [Related]
11. A case of nosocomial transmission of Crimean-Congo hemorrhagic fever from patient to patient.
Gürbüz Y; Sencan I; Oztürk B; Tütüncü E
Int J Infect Dis; 2009 May; 13(3):e105-7. PubMed ID: 18948048
[TBL] [Abstract][Full Text] [Related]
12. Crimean-Congo hemorrhagic fever: seroprevalence and risk factors among humans in Achaia, western Greece.
Sargianou M; Panos G; Tsatsaris A; Gogos C; Papa A
Int J Infect Dis; 2013 Dec; 17(12):e1160-5. PubMed ID: 24084247
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Crimean-Congo Hemorrhagic Fever Virus in Erzincan Province, Turkey, Relationship with Geographic Features and Risk Factors.
Cikman A; Aydin M; Gulhan B; Karakecili F; Kesik OA; Ozcicek A; Akin H; Kara M
Vector Borne Zoonotic Dis; 2016 Mar; 16(3):199-204. PubMed ID: 26808904
[TBL] [Abstract][Full Text] [Related]
14. Crimean-Congo hemorrhagic fever: prevention and control limitations in a resource-poor country.
Smego RA; Sarwari AR; Siddiqui AR
Clin Infect Dis; 2004 Jun; 38(12):1731-5. PubMed ID: 15227619
[TBL] [Abstract][Full Text] [Related]
15. Molecular and serological findings in suspected patients with Crimean-Congo hemorrhagic fever virus in Iran.
Karlberg H; Sharifi-Mood B; Mousavi-Jazi M; Dilcher M; Lindegren G; Mardani M; Bereskly S; Weidmann M; Mirazimi A
J Med Virol; 2015 Apr; 87(4):686-93. PubMed ID: 25649667
[TBL] [Abstract][Full Text] [Related]
16. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran.
Mardani M; Keshtkar-Jahromi M; Ataie B; Adibi P
Am J Trop Med Hyg; 2009 Oct; 81(4):675-8. PubMed ID: 19815885
[TBL] [Abstract][Full Text] [Related]
17. Crimean-Congo hemorrhagic fever.
Whitehouse CA
Antiviral Res; 2004 Dec; 64(3):145-60. PubMed ID: 15550268
[TBL] [Abstract][Full Text] [Related]
18. The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey.
Koksal I; Yilmaz G; Aksoy F; Erensoy S; Aydin H
Epidemiol Infect; 2014 Feb; 142(2):239-45. PubMed ID: 23688370
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial infections caused by Crimean-Congo haemorrhagic fever virus.
Tsergouli K; Karampatakis T; Haidich AB; Metallidis S; Papa A
J Hosp Infect; 2020 May; 105(1):43-52. PubMed ID: 31821852
[TBL] [Abstract][Full Text] [Related]
20. Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR.
Kubar A; Haciomeroglu M; Ozkul A; Bagriacik U; Akinci E; Sener K; Bodur H
Jpn J Infect Dis; 2011; 64(5):439-43. PubMed ID: 21937830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
